Silencing of the Wnt transcription factor TCF4 sensitizes colorectal cancer cells to (chemo-) radiotherapy

Carcinogenesis

Volumn 32, Issue 12, 2011, Pages 1824-1831

  Kendziorra, Emil ^a   Ahlborn, Kerstin ^a   Spitzner, Melanie ^a   Rave fränk, Margret ^a   Emons, Georg ^a   Gaedcke, Jochen ^a   Kramer, Frank ^a   Wolff, Hendrik A ^a   Becker, Heinz ^a   Beissbarth, Tim ^a   Ebner, Reinhard ^b   Ghadimi, B Michael ^a   Pukrop, Tobias ^a   Ried, Thomas ^b   Grade, Marian ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CYCLIN D1; DICKKOPF 1 PROTEIN; FLUOROURACIL; HISTONE H2AX; MYC PROTEIN; T CELL FACTOR PROTEIN; TRANSCRIPTION FACTOR 4; UNCLASSIFIED DRUG; WNT PROTEIN;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RESISTANCE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CHEMORADIOTHERAPY; COLONY FORMATION; COLORECTAL CANCER; CONTROLLED STUDY; DNA REPAIR; DOUBLE STRANDED DNA BREAK; GENE EXPRESSION PROFILING; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RADIOSENSITIZATION; REPORTER GENE; RNA INTERFERENCE; SENSITIZATION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TREATMENT RESPONSE; X RAY;

ANTINEOPLASTIC AGENTS; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; BETA CATENIN; BLOTTING, WESTERN; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; GENE SILENCING; GENES, REPORTER; HUMANS; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 81855217368     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgr222     Document Type: Article

References (47)

1. Glimelius,B. et al. (2009) Rectal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann. Oncol., 20 (Suppl. 4), 54-56.
2. Sauer,R. et al. (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N. Engl. J. Med., 351, 1731-1740.
3. Cunningham,D. et al. (2010) Colorectal cancer. Lancet, 375, 1030-1047.
4. Kuremsky,J.G. et al. (2009) Biomarkers for response to neoadjuvant chemoradiation for rectal cancer. Int. J. Radiat. Oncol. Biol. Phys., 74, 673-688.
5. Ghadimi,B.M. et al. (2005) Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradio-therapy. J. Clin. Oncol., 23, 1826-1838.
6. Moon,R.T. et al. (2004) WNT and beta-catenin signalling: diseases and therapies. Nat. Rev. Genet., 5, 691-701.
7. Clevers,H. (2006) Wnt/beta-catenin signaling in development and disease. Cell, 127, 469-480.
8. Klaus,A. et al. (2008) Wnt signalling and its impact on development and cancer. Nat. Rev. Cancer, 8, 387-398.
9. Arce,L. et al. (2006) Diversity of LEF/TCF action in development and disease. Oncogene, 25, 7492-7504.
10. Spitzner,M. et al. (2010) A gene expression signature for chemoradiosensitivity of colorectal cancer cells. Int. J. Radiat. Oncol. Biol. Phys., 78, 1184-1192.
11. Grade,M. et al. (2011) A genomic strategy for the functional validation of colorectal cancer genes identifies potential therapeutic targets. Int. J. Cancer, 128, 1069-1079.
12. Livak,K.J. et al. (2001) Analysis of relative gene expression data using realtime quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 25, 402-408.
13. Rodrigues,N.R. et al. (1990) p53 mutations in colorectal cancer. Proc. Natl Acad. Sci. USA, 87, 7555-7559.
14. Liu,Y. et al. (2006) Analysis of P53 mutations and their expression in 56 colorectal cancer cell lines. Proc. Natl Acad. Sci. USA, 103, 976-981.
15. Seiwert,T.Y. et al. (2007) The concurrent chemoradiation paradigm-general principles. Nat. Clin. Pract. Oncol., 4, 86-100.
16. O'Driscoll,M. et al. (2006) The role of double-strand break repair-insights from human genetics. Nat. Rev. Genet., 7, 45-54.
17. Lobrich,M. et al. (2010) gammaH2AX foci analysis for monitoring DNA double-strand break repair: strengths, limitations and optimization. Cell Cycle, 9, 662-669.
18. Bonner,W.M. et al. (2008) GammaH2AX and cancer. Nat. Rev. Cancer, 8, 957-967.
19. Rogakou,E.P. et al. (1999) Megabase chromatin domains involved in DNA double-strand breaks in vivo. J. Cell Biol., 146, 905-916.
20. Dikomey,E. et al. (1998) Correlation between cellular radiosensitivity and non-repaired double-strand breaks studied in nine mammalian cell lines. Int. J. Radiat. Biol., 73, 269-278.
21. He,T.C. et al. (1998) Identification of c-MYC as a target of the APC pathway. Science, 281, 1509-1512.
22. Tetsu,O. et al. (1999) Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature, 398, 422-426.
23. Niida,A. et al. (2004) DKK1, a negative regulator of Wnt signaling, is a target of the beta-catenin/TCF pathway. Oncogene, 23, 8520-8526.
24. Fingert,H.J. et al. (1986) Cytotoxic, cell cycle, and chromosomal effects of methylxanthines in human tumor cells treated with alkylating agents. Cancer Res., 46, 2463-2467.
25. Hartwell,L.H. et al. (1994) Cell cycle control and cancer. Science, 266, 1821-1828.
26. Davidson,G. et al. (2009) Cell cycle control of wnt receptor activation. Dev. Cell, 17, 788-799.
27. Davidson,G. et al. (2010) Emerging links between CDK cell cycle regulators and Wnt signaling. Trends Cell Biol., 20, 453-460.
28. van de Wetering,M. et al. (2002) The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell, 111, 241-250.
29. Giese,K. et al. (1993) LEF-1 contains an activation domain that stimulates transcription only in a specific context of factor-binding sites. EMBO J., 12, 4667-4676.
30. Love,J.J. et al. (1995) Structural basis for DNA bending by the architectural transcription factor LEF-1. Nature, 376, 791-795.
31. Giese,K. et al. (1997) Functional analysis of DNA bending and unwinding by the high mobility group domain of LEF-1. Proc. Natl Acad. Sci. USA, 94, 12845-12850.
32. Waterman,M.L. (2004) Lymphoid enhancer factor/T cell factor expression in colorectal cancer. Cancer Metastasis Rev., 23, 41-52.
33. Klemm,F. et al. (2011) Beta-catenin-independent WNT signaling in basal-like breast cancer and brain metastasis. Carcinogenesis, 32, 434-442.
34. Kikuchi,A. et al. (2008) Tumor formation due to abnormalities in the beta-catenin-independent pathway of Wnt signaling. Cancer Sci., 99, 202-208.
35. Sato,A. et al. (2010) Wnt5a regulates distinct signalling pathways by binding to Frizzled2. EMBO J., 29, 41-54.
36. Gonzalez-Sancho,J.M. et al. (2005) The Wnt antagonist DICKKOPF-1 gene is a downstream target of beta-catenin/TCF and is downregulated in human colon cancer. Oncogene, 24, 1098-1103.
37. Kim,J.K. et al. (2009) Nuclear cyclin D1: an oncogenic driver in human cancer. J. Cell Physiol., 220, 292-296.
38. Lamb,J. et al. (2003) Cyclin D1 and molecular chaperones: implications for tumorigenesis. Cell Cycle, 2, 525-527.
39. Jirawatnotai,S. et al. (2011) A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers. Nature, 474, 230-234.
40. Lucero,O.M. et al. (2010) A re-evaluation of the "oncogenic" nature of Wnt/beta-catenin signaling in melanoma and other cancers. Curr. Oncol. Rep., 12, 314-318.
41. Reya,T. et al. (2005) Wnt signalling in stem cells and cancer. Nature, 434, 843-850.
42. Fodde,R. et al. (2007) Wnt/beta-catenin signaling in cancer stemness and malignant behavior. Curr. Opin. Cell Biol., 19, 150-158.
43. Woodward,W.A. et al. (2007) WNT/beta-catenin mediates radiation resistance of mouse mammary progenitor cells. Proc. Natl Acad. Sci. USA, 104, 618-623.
44. Zhang,M. et al. (2009) Selective targeting of radiation-resistant tumorinitiating cells. Proc. Natl Acad. Sci. USA, 107, 3522-3527.
45. Flahaut,M. et al. (2009) The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/beta-catenin pathway. Oncogene, 28, 2245-2256.
46. Shou,J. et al. (2002) Human Dkk-1, a gene encoding a Wnt antagonist, responds to DNA damage and its overexpression sensitizes brain tumor cells to apoptosis following alkylation damage of DNA. Oncogene, 21, 878-889.
47. Kriegl,L. et al. (2010) LEF-1 and TCF4 expression correlate inversely with survival in colorectal cancer. J. Transl. Med., 8, 123.